Response of blood pressure after percutaneous transluminal renal artery angioplasty and stenting

doi:10.4330/wjc.v5.i7.247

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 7

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5230)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-5) series.

Item

Count

PDF

396

HTML

2841

Tables (1-5)

173

Sum=3410

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1019

Download

801

Sum=1820

Jul 26, 2013 (publication date) through Sep 1, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Cardiol. Jul 26, 2013; 5(7): 247-253
Published online Jul 26, 2013. doi: 10.4330/wjc.v5.i7.247

Table 4 Clinical features of resistant hypertensive group: Responsive vs unresponsive to percutaneous transluminal renal artery n (%)

		Group A	Group B	P value
		n = 26	n = 49	P value
	Male gender	24 (92.3)	33 (67.3)	0.016
	Smoker	22 (84.6)	33 (67.4)	0.1
	Ischemic heart disease	21 (80.8)	35 (71.4)	0.376
	Diabetes mellitus	8 (30.8)	19 (38.8)	0.49
	C/f of LVF	5 (19.2)	11 (22.4)	0.746
	Smoking	22 (84.6)	33 (67.4)	0.1
	Renal bruit	20 (76.9)	29 (59.2)	0.124
	Refractory HT	23 (88.5)	37 (75.5)	0.182
	LVH	14 (53.9)	14 (28.6)	0.031
	LAD	19 (73.1)	34 (69.4)	0.733
	TVD	12 (46.2)	13 (26.5)	0.08
Renal artery stenosis	Unilateral RAS	15 (57.7)	40 (81.6)	0.026
(unilat vs bilat)	Bilateral RAS	11 (42.3)	9 (18.4)	0.026
LMCA disease	Absent	23 (88.5)	47 (95.9)	0.218
LMCA disease	Present	3 (11.5)	2 (4.1)	0.218

Group A: Patients who did not show blood pressure reduction after percutaneous transluminal renal artery (PTRA) (26 patients); and group B: Patients who showed blood pressure reduction after PTRA (49 patients). HT: Hormone therapy; LVH: Left ventricular hypertrophy; TVD: Triple vessel disease; LAD: Left anterior descending; LVF: Left ventricular function; RAS: Renal artery stenosis; LMCA: Left main coronary artery.

Citation: Prajapati JS, Jain SR, Joshi H, Shah S, Sharma K, Sahoo S, Virparia K, Thakkar A. Response of blood pressure after percutaneous transluminal renal artery angioplasty and stenting. World J Cardiol 2013; 5(7): 247-253
URL: https://www.wjgnet.com/1949-8462/full/v5/i7/247.htm
DOI: https://dx.doi.org/10.4330/wjc.v5.i7.247